CCN2 and cancer: Like CYR61 and miR-205, CTGF has also been demonstrated to play both oncogenic and suppressor roles in a wide range of cancer cell types [45], [47], [49]–[51], and it is also involved in both EMT [52], [53] and the Akt pathway [54]–[56].